Search all trials

Find therapies in clinical trials near you – page 3

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Migraine

Recruiting

Registered drug

Study of incobotulinumtoxinA injections for prevention of chronic migraine in adult patients

Registered drug

Austria

Participants:18–64 years · 65+ years
Substances:Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins

Contact Research Centre

Vitiligo

Recruiting

Investigational

Study of ruxolitinib cream for children aged 6 to 12 years with non-segmental vitiligo

Investigational

Austria

Participants:0–17 years
Substances:Ruxolitinib

Contact Research Centre

Vitiligo+2

Recruiting

InvestigationalNo placebo

Long-term safety study of oral povorcitinib in patients with hidradenitis suppurativa, prurigo nodularis, or vitiligo who previously participated in clinical trials

InvestigationalNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Povorcitinib

Contact Research Centre

Cardiovascular disorder+2

Recruiting

Registered drug

Study of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease

Registered drug

Austria

Participants:18–64 years · 65+ years
Substances:Bi 690517

Contact Research Centre

Bronchiectasis

Recruiting

Investigational

Study of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis

Investigational

Austria

Participants:0–17 years · 18–64 years · 65+ years
Substances:Bi 1291583

Contact Research Centre

Crohn's disease

Recruiting

Investigational

Study of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:Tulisokibart

Contact Research Centre

Arteriosclerosis

Recruiting

Investigational

Study of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:Maridebart Cafraglutide

Contact Research Centre

Breast cancer

Recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of Trastuzumab Deruxtecan vs. Palbociclib-Based Drug Combination for Advanced HR-Positive, HER2-Low Breast Cancer Patients

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Abemaciclib

Contact Research Centre

Acute myocardial infarction

Recruiting

Registered drugNo placebo

Study on Managing Heart Attack Risk with Icosapent Ethyl and Drug Combination for Patients at High Risk of Another Heart Attack

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Colchicine

Contact Research Centre

Crohn's disease

Recruiting

Investigational

Study of RO7790121 (afimkibart) for Treatment and Long-term Management in Adults with Moderate to Severe Crohn's Disease

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:Ro7790121

Contact Research Centre

Pyoderma gangrenosum

Recruiting

Investigational

Study on Spesolimab for Adults with Pyoderma Gangrenosum Requiring Systemic Therapy

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:Spesolimab

Contact Research Centre

Systemic scleroderma+1

Recruiting

Investigational

Study of Amlitelimab and BI 1015550 for Patients with Interstitial Lung Disease Due to Scleroderma

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:Amlitelimab

Contact Research Centre

Find therapies in clinical trials near you – page 3

1 110 trials match your criteria

Migraine

Study of incobotulinumtoxinA injections for prevention of chronic migraine in adult patients

Vitiligo

Study of ruxolitinib cream for children aged 6 to 12 years with non-segmental vitiligo

Vitiligo+2

Long-term safety study of oral povorcitinib in patients with hidradenitis suppurativa, prurigo nodularis, or vitiligo who previously participated in clinical trials

Cardiovascular disorder+2

Study of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease

Bronchiectasis

Study of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis

Crohn's disease

Study of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease

Arteriosclerosis

Study of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease

Breast cancer

Study on the Safety and Effectiveness of Trastuzumab Deruxtecan vs. Palbociclib-Based Drug Combination for Advanced HR-Positive, HER2-Low Breast Cancer Patients

Acute myocardial infarction

Study on Managing Heart Attack Risk with Icosapent Ethyl and Drug Combination for Patients at High Risk of Another Heart Attack

Crohn's disease

Study of RO7790121 (afimkibart) for Treatment and Long-term Management in Adults with Moderate to Severe Crohn's Disease

Pyoderma gangrenosum

Study on Spesolimab for Adults with Pyoderma Gangrenosum Requiring Systemic Therapy

Systemic scleroderma+1

Study of Amlitelimab and BI 1015550 for Patients with Interstitial Lung Disease Due to Scleroderma

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.